Leverage Partners Absolute Return Fund Spc Eli Lilly & CO Call Options Transaction History

Leverage Partners Absolute Return Fund Spc

$76.9 Million
Q3 2024

Call Options

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q1 2024 May 07, 2024	BUY	$592.2 - $792.28 $593,384 - $793,864	1,002 New	1,002 $780,000
Q3 2023 Nov 06, 2023	BUY	$434.7 - $599.3 $1.1 Million - $1.52 Million	2,535 New	2,535 $1.36 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$76.9 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$58.6 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$52.3 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$40.8 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$26.9 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Leverage Partners Absolute Return Fund Spc, based on Form 13F filings with the SEC.

News

Stay updated on Leverage Partners Absolute Return Fund Spc with notifications on news.

Account